Overexpression of LPA1 and LPA2 was readily observed in breast cancers with redundant mediation functions in multiple endogenous LPA responses, including cancer cell growth, metastasis, angiogenesis, and chemoresistance [8, 11–13]. This evidence concerns the gene LPAR2 and breast carcinoma.